Drug Trial Radar · NCT06911216
A Pharmacokinetics (PK) Study in Healthy Adults
Last checked: Nov 20, 2026Latest source record: Apr 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
8
Actual
Start
Mar 17, 2025
Primary completion
Apr 7, 2025
Study completion Apr 7, 2025
Sponsor
- Lead sponsor
- Santen Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Apr 4, 2025
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is to characterize STN1013800 active ingredient bioavailability following multiple-dose ocular administration of STN1013800 to both eyes in healthy adults. It is a PK study with screening period of up to 28 days + dosing period of 7 days + Follow-up period of 2 days. At present, there are no medicines for the treatment of acquired blepharoptosis in China. Therefore, efficacy and safety phase III study is also currently being conducted.
Conditions
- Blepharoptosis
Interventions
STN1013800 ophthalmic solutionDrug
Investigational Product: 0.1% STN1013800 ophthalmic solution once daily (QD) (9AM ± 60 min), one drop for each eye
Primary outcomes
What the sponsor says the trial is designed to measure.
- PK (Pharmacokinetic) parameter to measure: CmaxTime frame: Day 1, 5, 6, and 7
- PK parameter to measure: CminTime frame: Day 1, 5, 6, and 7
- PK parameter to measure: TmaxTime frame: Day 1, 5, 6, and 7
- PK parameter to measure: AUC0-24hTime frame: Day 1, 5, 6, and 7
- PK parameter to measure: AUC0-36hTime frame: Day 1, 5, 6, and 7
- PK parameter to measure: AUCinfTime frame: Day 1, 5, 6, and 7
- PK parameter to measure: kelTime frame: Day 1, 5, 6, and 7
- PK parameter to measure: t½Time frame: Day 1, 5, 6, and 7
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Beijing Chaoyang Hospital, Capital Medical University
Beijing, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.